CommSec Advisory’s Nicky Kritikos speaks with Tom Piotrowski about plans by Woolworths to cut 500 jobs as part of a $1bn restructure, upcoming earnings results due from ResMed and Thursday’s US FOMC decision Find out more at https://www.commsec.com.au/market-news/the-markets.html Show More
Resmed has acquired CareTouch, a US-based provider of internet solutions and therapy-focused resupply programs for home medical equipment providers (HMEs). Founded in 2003, CareTouch provides HMEs an easy-to-use solution for managing and monitoring patient populations, with customised patient engagement protocols and automated interactive voice response as well as live multi-lingual... Show More
Resmed (ASX: RMD) has released the preliminary results of the Serve-HF trail for patients with Chronic Heart Failures. The trial identified an increased risk of cardiovascular mortality for patients that received ventilation therapy. Show More
Resmed Inc (RMD) applies for coding for flow-generator platform. Appears poised to launch Airsense 10 and is due to announce its 4Q14 results tomorrow. History suggests that new product platforms are a significant driver of revenue and earnings growth. Our analysis indicates that the market is likely to re-rate RMD's PE multiple... Show More
We wrote about ResMed (RMD) a few months ago in Livewire, warning of the downside. Patience has paid off for our readers and it has now become a buying opportunity. A quick summary of the fundamentals: 1. Leveraged to sleeping disorder volumes due to higher obesity rates in developed nations. 2. High... Show More
From @morgans following the Resmed (RMD) result on Friday: Resmed (RMD, Hold, Price Target A$5.40) - 2QFY14 earnings were below expectations as volumes and pricing continue to be affected by competition and US distributor distractions due to competitive bidding. While we continue to see offsets and remain optimistic of long-term... Show More